Sunday, August 19, 2018

WHO classifies bedaquiline as priority drug in multi-drug resistant TB treatment

WHO classifies bedaquiline as priority drug in multi-drug resistant TB treatment WHO, however, warned that it does not have evidence on the safety and effectiveness of bedaquiline use beyond six months, as it was insufficient for review

from Moneycontrol Business News https://ift.tt/2MCCN7h

No comments:

Post a Comment

Bitcoin stays near $64K, Ethereum underperforms as weak risk appetite keeps crypto markets under pressure

Bitcoin traded near $64,000 and Ethereum underperformed as risk appetite weakened. The global crypto market capitalization edged down 2% to ...